Art. 41 Directive (EU) 2001/83

In forcecited 2×

In order to obtain the manufacturing authorization, the applicant shall meet at least the following requirements:

(a)

specify the medicinal products and pharmaceutical forms which are to be manufactured or imported and also the place where they are to be manufactured and/or controlled;

(b)

have at his disposal, for the manufacture or import of the above, suitable and sufficient premises, technical equipment and control facilities complying with the legal requirements which the Member State concerned lays down as regards both manufacture and control and the storage of medicinal products, in accordance with Article 20;

(c)

have at his disposal the services of at least one qualified person within the meaning of Article 48.

The applicant shall provide particulars in support of the above in his application.

  • Arrêt du Tribunal (septième chambre) du 7 mars 2013. Acino AG (anciennement Acino Pharma GmbH) contre Commission européenne.Decision

    Dazu ist festzustellen, dass zwar nach Art. 41 der Richtlinie 2001/83 die Einhaltung der guten Herstellungspraxis keine Anforderung für den Erhalt einer Herstellungsgenehmigung ist, weil eine Herstellung gemäß der guten …

    7 Mar 2013 · 62010TJ0539

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 25 July 2018. Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and OthersDecision

    Articles 41 to 53 of Directive 2001/83 specify the conditions that those national authorisation regimes must satisfy. In particular, the manufacturer in question must make an application and supply a range of information in support of it. …

    25 Jul 2018 · 62017CC0029